{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T15:19:33Z","timestamp":1791299973109,"version":"4.1.0"},"reference-count":68,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,1,1]],"date-time":"2012-01-01T00:00:00Z","timestamp":1325376000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1016\/j.expneurol.2011.11.031","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T13:55:53Z","timestamp":1323352553000},"page":"513-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain"],"prefix":"10.1016","volume":"233","author":[{"given":"D.","family":"Domenger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Dea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Theroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Moquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Gratton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Poirier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2011.11.031_bb0005","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/ana.410370219","article-title":"Plasticity of nerve afferents to nigrostriatal neurons in Parkinson's disease","volume":"37","author":"Anglade","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0010","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1523\/JNEUROSCI.17-02-00516.1997","article-title":"Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 allele","volume":"17","author":"Arendt","year":"1997","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0345","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/1098-2396(20001201)38:3<363::AID-SYN16>3.0.CO;2-A","article-title":"Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice","volume":"38","author":"Bezard","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0025","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(95)01391-1","article-title":"Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra","volume":"709","author":"Blanchard","year":"1996","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0030","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1471-4159.2006.04241.x","article-title":"Dopamine and adult neurogenesis","volume":"100","author":"Borta","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0035","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI112130","article-title":"Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system","volume":"76","author":"Boyles","year":"1985","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0040","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1172\/JCI113943","article-title":"A role for apolipoprotein E, apolipoprotein A-I, and low density lipoprotein receptors in cholesterol transport during regeneration and remyelination of the rat sciatic nerve","volume":"83","author":"Boyles","year":"1989","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0045","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0022-2275(20)31622-9","article-title":"Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth","volume":"42","author":"DeMattos","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0050","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1007\/BF01485901","article-title":"Distribution of noradrenaline and dopamine (3-hydroxytyramine) in the human brain and their behavior in diseases of the extrapyramidal system","volume":"38","author":"Ehringer","year":"1960","journal-title":"Klin. Wochenschr."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0055","doi-asserted-by":"crossref","first-page":"30121","DOI":"10.1074\/jbc.271.47.30121","article-title":"Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein","volume":"271","author":"Fagan","year":"1996","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0306-4522(00)00009-9","article-title":"Axonal sprouting following lesions of the rat substantia nigra","volume":"97","author":"Finkelstein","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0892-0362(94)00048-I","article-title":"Neuroglial responses to the dopaminergic neurotoxicant 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mouse striatum","volume":"17","author":"Francis","year":"1995","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0070","doi-asserted-by":"crossref","first-page":"25754","DOI":"10.1074\/jbc.M502143200","article-title":"The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice","volume":"280","author":"Fryer","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0075","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nn2058","article-title":"A molecular pathway of neurodegeneration linking alpha-synuclein to ApoE and Abeta peptides","volume":"11","author":"Gallardo","year":"2008","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0080","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0022-2275(20)41390-2","article-title":"Effects of apolipoprotein E, beta-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro","volume":"33","author":"Handelmann","year":"1992","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0350","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0028-3908(85)90090-5","article-title":"Partial lesions of the nigrostriatal pathway in the rat. Acceleration of transmitter synthesis and release of surviving dopaminergic neurones by drugs","volume":"24","author":"Hefti","year":"1985","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0355","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0095","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/ana.410270615","article-title":"Does adrenal graft enhance recovery of dopaminergic neurons in Parkinson's disease?","volume":"27","author":"Hirsch","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0100","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1073\/pnas.92.21.9480","article-title":"Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line","volume":"92","author":"Holtzman","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0110","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1212\/01.WNL.0000130159.28215.6A","article-title":"APOE-[epsilon]2 allele associated with higher prevalence of sporadic Parkinson disease","volume":"62","author":"Huang","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1001\/archneur.63.2.189","article-title":"Apolipoprotein E and dementia in Parkinson disease: a meta-analysis","volume":"63","author":"Huang","year":"2006","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0115","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1073\/pnas.83.4.1125","article-title":"Expression of apolipoprotein E during nerve degeneration and regeneration","volume":"83","author":"Ignatius","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0120","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/jnr.20607","article-title":"Traumatic brain injury induces biphasic upregulation of ApoE and ApoJ protein in rats","volume":"82","author":"Iwata","year":"2005","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0125","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1073\/pnas.82.7.2173","article-title":"Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity","volume":"82","author":"Javitch","year":"1985","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0360","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/NEN.0b013e3181713cb1","article-title":"Striatal beta-amyloid deposition in Parkinson disease with dementia","volume":"67","author":"Jellinger","year":"2008","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s007020200027","article-title":"Impact of coexistent Alzheimer pathology on the natural history of Parkinson's disease","volume":"109","author":"Jellinger","year":"2002","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0140","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/ana.410370215","article-title":"Apolipoprotein E genotypes in Parkinson's disease with and without dementia","volume":"37","author":"Koller","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.neulet.2009.11.034","article-title":"GFAP reactivity, apolipoprotein E redistribution and cholesterol reduction in human astrocytes treated with alpha-synuclein","volume":"469","author":"Koob","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0150","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0197-0186(01)00050-X","article-title":"Apolipoprotein E and apolipoprotein E receptors modulate A beta-induced glial neuroinflammatory responses","volume":"39","author":"LaDu","year":"2001","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0365","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0160","doi-asserted-by":"crossref","first-page":"974361","DOI":"10.4061\/2011\/974361","article-title":"Function and comorbidities of apolipoprotein e in Alzheimer's disease","volume":"2011","author":"Leduc","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0165","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/bmj.3.5776.690","article-title":"Parkinsonism\u2013neuropathology","volume":"3","author":"Lewis","year":"1971","journal-title":"Br. Med. J."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0170","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1212\/01.WNL.0000128089.53030.AC","article-title":"Apolipoprotein E controls the risk and age at onset of Parkinson disease","volume":"62","author":"Li","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neuron.2007.08.008","article-title":"Amyloid precursor protein regulates brain apolipoprotein E and cholesterol metabolism through lipoprotein receptor LRP1","volume":"56","author":"Liu","year":"2007","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0175","doi-asserted-by":"crossref","first-page":"17068","DOI":"10.1523\/JNEUROSCI.4067-10.2010","article-title":"Neuronal LRP1 knockout in adult mice leads to impaired brain lipid metabolism and progressive, age-dependent synapse loss and neurodegeneration","volume":"30","author":"Liu","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0185","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0022-3565(25)30363-0","article-title":"The neurochemistry of Parkinson's disease: effect of L-dopa therapy","volume":"195","author":"Lloyd","year":"1975","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0370","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0195","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","article-title":"Apolipoprotein E4: A causative factor and therapeutic target in neuropathology, including Alzheimer's disease","volume":"103","author":"Mahley","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0200","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0301-0082(96)00038-X","article-title":"Alterations in apolipoprotein E expression during aging and neurodegeneration","volume":"50","author":"Masliah","year":"1996","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0205","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/brain\/awm208","article-title":"A new model to study compensatory mechanisms in MPTP-treated monkeys exhibiting recovery","volume":"130","author":"Mounayar","year":"2007","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0210","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/jnen\/59.5.408","article-title":"Alpha-synuclein inclusions in Alzheimer and Lewy body diseases","volume":"59","author":"Mukaetova-Ladinska","year":"2000","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0215","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.nbd.2004.01.015","article-title":"Low-density lipoprotein receptor-knockout mice display impaired spatial memory associated with a decreased synaptic density in the hippocampus","volume":"16","author":"Mulder","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0375","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.8171342","article-title":"Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro","volume":"264","author":"Nathan","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0225","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0306-4522(97)00661-1","article-title":"Dissociation of apolipoprotein and apolipoprotein receptor response to lesion in the rat brain: an in situ hybridization study","volume":"85","author":"Page","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0230","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.expneurol.2010.01.004","article-title":"Transient elevation of adult hippocampal neurogenesis after dopamine depletion","volume":"222","author":"Park","year":"2010","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0235","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1097\/00005072-199111000-00006","article-title":"The neuropathologic basis of different clinical subgroups of Parkinson's disease","volume":"50","author":"Paulus","year":"1991","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0240","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/jnr.20730","article-title":"Behavioral motor recovery in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned squirrel monkey (Saimiri sciureus): changes in striatal dopamine and expression of tyrosine hydroxylase and dopamine transporter proteins","volume":"83","author":"Petzinger","year":"2006","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0245","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0250","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1600-0773.1988.tb01875.x","article-title":"Studies on the acute and long-term changes in dopamine and noradrenaline metabolism in mouse brain following administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)","volume":"62","author":"Pileblad","year":"1988","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0255","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/0166-2236(94)90156-2","article-title":"Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease","volume":"17","author":"Poirier","year":"1994","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0380","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1749-6632.2000.tb05564.x","article-title":"Apolipoprotein E and Alzheimer's disease. A role in amyloid catabolism","volume":"924","author":"Poirier","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0270","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-328X(91)90111-A","article-title":"Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning","volume":"11","author":"Poirier","year":"1991","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0265","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/0140-6736(93)91705-Q","article-title":"Apolipoprotein E polymorphism and Alzheimer's disease","volume":"342","author":"Poirier","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0275","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0306-4522(93)90456-P","article-title":"Cholesterol synthesis and lipoprotein reuptake during synaptic remodelling in hippocampus in adult rats","volume":"55","author":"Poirier","year":"1993","journal-title":"Neuroscience"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0280","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S1566-2772(01)00019-6","article-title":"MPTP: a review of its mechanisms of neurotoxicity","volume":"1","author":"Przedborski","year":"2001","journal-title":"Clin. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0285","doi-asserted-by":"crossref","first-page":"8160","DOI":"10.1073\/pnas.84.22.8160","article-title":"Subcellular Compartmentalization of 1-methyl-4-phenylpyridinium with Catecholamines in Adrenal Medullary Chromaffin Vesicles May Explain the Lack of Toxicity to Adrenal Chromaffin Cells","volume":"84","author":"Reinhard","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0290","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2011.11.031_bb0300","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1523\/JNEUROSCI.10-07-02373.1990","article-title":"The process of reinnervation in the dentate gyrus of adult rats: time course of increases in mRNA for glial fibrillary acidic protein","volume":"10","author":"Steward","year":"1990","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0295","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/exnr.1993.1187","article-title":"The process of reinnervation in the dentate gyrus of adult rats: temporal relationship between changes in the levels of glial fibrillary acidic protein (GFAP) and GFAP mRNA in reactive astrocytes","volume":"124","author":"Steward","year":"1993","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0305","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0361-9230(86)90119-X","article-title":"Astrocyte responses to dopaminergic denervations by 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as evidenced by glial fibrillary acidic protein immunohistochemistry","volume":"17","author":"Str\u00f6mberg","year":"1986","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0310","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1600-0773.1997.tb00051.x","article-title":"Comparison of key steps in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in rodents","volume":"81","author":"Sundstr\u00f6m","year":"1997","journal-title":"Pharmacol. Toxicol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0385","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/0006-8993(87)90986-3","article-title":"Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL\/6 mice. Comparison with three other strains of mice","volume":"405","author":"Sundstr\u00f6m","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0320","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0024-3205(84)90112-7","article-title":"Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain & heart","volume":"35","author":"Wallace","year":"1984","journal-title":"Life Sci."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0325","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1006\/exnr.2001.7655","article-title":"Alterations in ApoE and ApoJ in relation to degeneration and regeneration in a mouse model of entorhinal cortex lesion","volume":"169","author":"White","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0330","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1073\/pnas.0937239100","article-title":"NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease","volume":"100","author":"Wu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0335","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1001\/archneur.1984.04050190062015","article-title":"Neurochemical compensation after nigrostriatal bundle injury in an animal model of preclinical parkinsonism","volume":"41","author":"Zigmond","year":"1984","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.expneurol.2011.11.031_bb0340","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1146\/annurev.ne.12.030189.002215","article-title":"Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation","volume":"12","author":"Zigmond","year":"1989","journal-title":"Annu. Rev. Neurosci."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611004353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488611004353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:45:46Z","timestamp":1762148746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488611004353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,1]]},"references-count":68,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["S0014488611004353"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.11.031","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2012,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The MPTP neurotoxic lesion model of Parkinson's disease activates the apolipoprotein E cascade in the mouse brain","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2011.11.031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}